Why the study?
Guideline-adherent oral anticoagulant use reduces stroke and thromboembolism in high-risk patients with ischemic stroke and atrial fibrillation, but data on OAC use in China are underreported.
Does adherence to guideline-recommended oral anticoagulant prescription at discharge improve over time, and what factors are associated with non-prescription in patients with ischemic stroke and atrial fibrillation?
Does adherence to guideline-recommended oral anticoagulant prescription at discharge improve over time, and what factors are associated with non-prescription in patients with ischemic stroke and atrial fibrillation?
Despite significant temporal improvements from 2015 to 2019, guideline-directed oral anticoagulant prescription rates at discharge remain low for Chinese patients with ischemic stroke and atrial fibrillation.
No takes yet. Share an insight, caveat, or question.
Despite temporal gains, OAC rates remain low in Chinese AF-stroke patients; leaves open whether targeted interventions can improve adherence.
Gu et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: